For NAFLD, genetic variability in PNPLA3, TM6SF2, MBOAT7, GCKR, HSD17B13, and other genes was found to be associated with the prevalence of NAFLD and disease progression [32,33,34,35]. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.